NCT07847567Not yet recruiting
Building Rapid Inpatient Delivery of ART to Generate Engagement in HIV Care
Building Rapid Inpatient Delivery of ART to Generate Engagement in HIV Care (BRIDGE)
Source: ClinicalTrials.gov · Last updated 29 Sept 2026
Brief summary (registry, in English)
The study team will pilot rapid antiretroviral therapy (ART) initiation as part of routine inpatient care at the University of Chicago Medicine (UCM), comparing outcomes over a 12-month implementation period. Electronic medical record (EMR) data will be used to evaluate clinical outcomes such as ART initiation within 24-48 hours, linkage to HIV care, retention, and viral suppression, as well as demographic and clinical factors associated with these outcomes. Implementation outcomes will be assessed using Proctor's framework, including acceptability, feasibility, fidelity, and appropriateness.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 15 Sept 2026
- Start date
- Feb 2027
- Primary completion date
- Feb 2028
- Lead sponsor
- University of Chicago
- Diseases
- HIV
- NCT number
- NCT07847567
What you commit to
- Study type: Observational
- Planned participants: 40
- From Feb 2027 to the primary completion date, Feb 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Not living with HIV
- HIV viral load \< 200 copies/mL
Age
- Less than 18 years of age
Other
- Not admitted to the UCM General Medicine or Hospital Medicine wards during the study time period
- Not able to speak and understand English
- Unable and/or unwilling to provide informed consent
Who the study is looking for
- 18 years of age or older
- Admitted to the UCM General Medicine or Hospital Medicine wards during the study time period
- Living with HIV
- HIV viral load \> 200 copies/mL
- Able to speak and understand English
- Able and willing to provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Chicago Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.